Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ · Financial Services
Bellevue Life Sciences Acquisition Corp. Total Liabilities 2021–2023
Bellevue Life Sciences Acquisition Corp. annual total liabilities history from 2020 to 2023. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bellevue Life Sciences Acquisition Corp. total liabilities as of December 31, 2023: 4.1M, a 225.19% increase year-over-year.
- Bellevue Life Sciences Acquisition Corp. total liabilities for 2023 were 4.1M, a 225.19% increase from 2022.
- Bellevue Life Sciences Acquisition Corp. total liabilities for 2022 were 1.3M, a 78.64% increase from 2021.
- Bellevue Life Sciences Acquisition Corp. total liabilities for 2021 were 707,207, a 119.93% increase from 2020.
- Bellevue Life Sciences Acquisition Corp. total liabilities for 2020 were 321,561.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bellevue Life Sciences Acquisition Corp. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2023 | $4 |
| 2022 | $1 |
| 2021 | $1 |
| 2020 | $0 |
Bellevue Life Sciences Acquisition Corp. Total Liabilities — FAQ
Bellevue Life Sciences Acquisition Corp. (BLAC) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLAC's total liabilities history?
The chart and table above show Bellevue Life Sciences Acquisition Corp.'s total liabilities by year and by quarter, including the growth rate.